UA130320U - PHARMACEUTICAL COMPOSITION FOR ORAL APPLICATION FOR TREATMENT OF INFECTIOUS DISEASES - Google Patents
PHARMACEUTICAL COMPOSITION FOR ORAL APPLICATION FOR TREATMENT OF INFECTIOUS DISEASESInfo
- Publication number
- UA130320U UA130320U UAU201803996U UAU201803996U UA130320U UA 130320 U UA130320 U UA 130320U UA U201803996 U UAU201803996 U UA U201803996U UA U201803996 U UAU201803996 U UA U201803996U UA 130320 U UA130320 U UA 130320U
- Authority
- UA
- Ukraine
- Prior art keywords
- pharmaceutically acceptable
- treatment
- pharmaceutical composition
- infectious diseases
- oral application
- Prior art date
Links
Landscapes
- Medicinal Preparation (AREA)
Abstract
Фармацевтична композиція для перорального застосування для лікування інфекційних захворювань містить моксифлоксацин у формі фармацевтично прийнятної солі, та фармацевтично прийнятні допоміжні речовини. Додатково містить манітол. Як фармацевтичну прийнятну сіль моксифлоксацину містить моксифлоксацину гідрохлорид моногідрат, як фармацевтично прийнятні допоміжні речовини містить целюлозу мікрокристалічну, натрію кроскармелозу, магнію стеарат, гіпромелозу, титану діоксид, макрогол 400.A pharmaceutical composition for oral administration for the treatment of infectious diseases contains moxifloxacin in the form of a pharmaceutically acceptable salt, and pharmaceutically acceptable excipients. Additionally contains mannitol. As a pharmaceutically acceptable salt of moxifloxacin contains moxifloxacin hydrochloride monohydrate, as pharmaceutically acceptable excipients it contains microcrystalline cellulose, croscarmellose sodium, magnesium stearate, hypromellose, titanium dioxide, macrogol 400.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
UAU201803996U UA130320U (en) | 2018-04-12 | 2018-04-12 | PHARMACEUTICAL COMPOSITION FOR ORAL APPLICATION FOR TREATMENT OF INFECTIOUS DISEASES |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
UAU201803996U UA130320U (en) | 2018-04-12 | 2018-04-12 | PHARMACEUTICAL COMPOSITION FOR ORAL APPLICATION FOR TREATMENT OF INFECTIOUS DISEASES |
Publications (1)
Publication Number | Publication Date |
---|---|
UA130320U true UA130320U (en) | 2018-12-10 |
Family
ID=64603979
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
UAU201803996U UA130320U (en) | 2018-04-12 | 2018-04-12 | PHARMACEUTICAL COMPOSITION FOR ORAL APPLICATION FOR TREATMENT OF INFECTIOUS DISEASES |
Country Status (1)
Country | Link |
---|---|
UA (1) | UA130320U (en) |
-
2018
- 2018-04-12 UA UAU201803996U patent/UA130320U/en unknown
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PH12017501421A1 (en) | Pharmaceutical compositions comprising n-(3,5-dimethoxyphenyl)-n`-(1-methylethyl)-n-[3-(1-methyl-1h-pyrazol-4-yl)quinoxalin-6-yl]ethane-1,2-diamine | |
JP2014533733A5 (en) | ||
JP2016163571A5 (en) | ||
RU2016144479A (en) | PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF DISEASES MEDIATED BY FLOUR-VISCIDOUS TRANSMEMBRANE CONDUCTIVITY REGULATOR | |
MX2016010179A (en) | Donepezil compositions and method of treating alzheimer's disease. | |
MX2018008021A (en) | Methods and compositions for the treatment of seizure-related disorders. | |
WO2018165404A8 (en) | Pharmaceutical formulations of phloroglucinol and trimethylphloroglucinol | |
RU2018136580A (en) | CITRIC SALT (S) -4 - ((S) -3-fluorine-3- (2- (5,6,7,8-tetrahydro-1,8-naphthyridine-2-yl) ethyl) pyrrolidin-1-yl ) -3- (3- (2-METHOXYETHOXY) PHENYL) BUTANIC ACID | |
MX2021002321A (en) | Novel methods. | |
MX2021004457A (en) | Pharmaceutical composition for oral administration comprising aminopyrimidine derivative or its salt. | |
WO2017182873A3 (en) | Peptide-oligourea foldamer compounds and methods of their use | |
EA201291104A1 (en) | ORAL MEDICINAL FORMS BENDAMUSTIN | |
JP2018530566A5 (en) | ||
JP2016530238A5 (en) | ||
JP2017523149A5 (en) | ||
UA130320U (en) | PHARMACEUTICAL COMPOSITION FOR ORAL APPLICATION FOR TREATMENT OF INFECTIOUS DISEASES | |
WO2011080570A8 (en) | Extended release pharmaceutical composition comprising linezolid and process for preparing the same | |
WO2016122288A3 (en) | Combined formulation including verbenone derivative and therapeutic agent for reperfusion for preventing or treating cerebrovascular diseases, arteriosclerosis or cardiovascular disease | |
MX2021014093A (en) | Compositions and methods for treating alzheimer's disease and parkinson's disease. | |
RU2736479C1 (en) | Excipient-free pharmaceutical composition containing fenosanic acid | |
MX2017012999A (en) | Pyrrolidone carboxylic acid (pca) for ophthalmic use. | |
WO2024039897A3 (en) | Adagrasib solid pharmaceutical compositions | |
ZA202204907B (en) | Orally disintegrating pharmaceutical compositions of apixaban | |
ZA202200330B (en) | Pharmaceutical composition of imatinib | |
MX2021016044A (en) | Dichlorphenamide compositions and methods of use. |